ArticleMedical oncology (Northwood, London, England)2012

Phase I clinical trial of continuous infusion of tyroserleutide in patients with advanced hepatocellular carcinoma.

Zhen-Yu Xiao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.